Creamino® obtains US approval for all poultry species
Creamino®, AlzChem’s source of creatine for animal nutrition, is now authorised in the US for use as feed additive for all types of poultry.
The extension of the current feed additive status of guanidinoacetic acid – successfully progressed by AlzChem – became effective with publication in the Code of Federal Regulation in July 2021.
Creamino® was originally approved for use in growing broilers and turkeys in 2016. With this approval extension, AlzChem now has the right to sell Creamino® for all breeders as well as commercial layers. Although the market for breeders is smaller compared to growing broilers and turkeys, it is a market historically short supplied by feed ingredient manufacturers. Creamino® offers proven benefits in hatchability, progeny performance and egg production.
About Creamino®
Creamino® is a patent protected preparation of guanidinoacetic acid (GAA). GAA is the direct endogenous precursor of creatine in the organism of all vertebrates. The body produces GAA from the amino acids glycine and arginine and then converts GAA to creatine with the help of methionine. However, this endogenous synthethis is not sufficient to meet daily needs. Until now, there is no Creatine in feed. Creatine is an essential biomolecule for proper function of energy transfer and supply. Thereby Creatine supports various functions in the body, such as healthy growth, immune system or reproduction. In contrast to other nutrients creatine directly reloads ATP for energy supply, making sure that sufficient energy is at any time and any place available in the body.
With Creamino®, we supply a unique source of creatine supporting many important body functions, delivering energy for healthy growth.
About AlzChem
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, AlzChem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. AlzChem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of AlzChem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. AlzChem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
Contact
Andreas Oebbeke